VEGFA and neoplasm: Additionally, S1PR2 expression is seen in host endothelial cells and tumor-infiltrating bone marrow cells, where it suppresses the expression of vascular endothelial growth factor and matrix metalloproteinase-9 activity to prevent tumor angiogenesis and tumor growth (111).